--- title: "GRI Bio (GRI.US) — 财务报表" type: "Symbol" locale: "zh-CN" url: "https://longbridge.com/zh-CN/quote/GRI.US/norm.md" symbol: "GRI.US" name: "GRI Bio" parent: "https://longbridge.com/zh-CN/quote/GRI.US.md" datetime: "2026-03-16T10:06:54.277Z" locales: - [en](https://longbridge.com/en/quote/GRI.US/norm.md) - [zh-CN](https://longbridge.com/zh-CN/quote/GRI.US/norm.md) - [zh-HK](https://longbridge.com/zh-HK/quote/GRI.US/norm.md) --- > 支持的语言: [English](https://longbridge.com/en/quote/GRI.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/GRI.US/norm.md) # GRI Bio (GRI.US) — 财务报表 ## 利润表 (USD) | 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | | --- | --- | --- | --- | --- | --- | | EPS | -13.25 | -35.88 | -36.72 | -162.31 | -220.02 | | ROE | -265.87% | -505.59% | -511.07% | -465.30% | -401.35% | | Revenue | - | - | - | - | - | | Net income | -2.66M | -3.36M | -2.89M | -3.05M | -3.86M | | Operating income | -2.66M | -3.37M | -2.90M | -3.05M | -1.95M | | Gross margin | - | - | - | - | - | | Net margin | - | - | - | - | - | | Profit quality | - | - | - | - | - | ## 资产负债表 (USD) | 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | | --- | --- | --- | --- | --- | --- | | A&L | 8.67M | 4.78M | 5.67M | 4.04M | 5.74M | | Leverage | 1.44 | 2.40 | 1.71 | 3.35 | 1.42 | | BVPS | 12.07 | 17.07 | 37.25 | 64.22 | 214.85 | | Turnover | - | - | - | - | - | | Cash & STI | 8.23M | 4.05M | 5.12M | 3.28M | 5.03M | | Inv & Rec | - | - | - | - | - | | LT assets | 74000.00 | 85000.00 | 99000.00 | 112000.00 | 124000.00 | | Net debt | -8.16M | -3.97M | -5.03M | -3.17M | -4.91M | ## 现金流量表 (USD) | 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | | --- | --- | --- | --- | --- | --- | | Operating CF | -2.97M | -2.31M | -3.17M | -1.74M | -2.00M | | Investing CF | -3000.00 | - | - | - | - | | Financing CF | 7.15M | 1.25M | 5.01M | -11000.00 | 2.28M | | Free CF | -1.44M | -1.38M | -2.05M | -606875.00 | -1.27M | | OCF coverage | -99033.33% | - | - | - | - | | Repaid & issued | - | - | - | - | - | | CapEx | -3000.00 | - | - | - | - |